Mia's Feed
Medical News & Research

Kennedy Announces Changed COVID Vaccination Recommendations for Healthy Children and Pregnant Women

Kennedy Announces Changed COVID Vaccination Recommendations for Healthy Children and Pregnant Women

Share this article

U.S. Health Secretary Kennedy announces that COVID-19 vaccines are no longer recommended for healthy children and pregnant women, citing lack of clinical evidence and shifting policy strategies.

2 min read

U.S. Health Secretary Robert F. Kennedy Jr. has recently declared that COVID-19 vaccinations are no longer advised for healthy children and pregnant women. This decision was communicated through a brief 58-second video shared on the social media platform X, where Kennedy indicated that COVID-19 shots have been removed from the CDC's official recommendations for these groups. The video did not feature CDC representatives, and officials from the CDC redirected inquiries to Kennedy and the Department of Health and Human Services.

Historically, U.S. health authorities, guided by infectious disease experts, have recommended annual COVID-19 booster shots for all Americans from 6 months of age and older. A CDC advisory panel is scheduled to meet in June to discuss vaccination strategies for the upcoming fall, with considerations including targeting high-risk populations and offering vaccination choices to lower-risk groups.

Kennedy, known for his opposition to vaccines before his appointment as health secretary, argued that there is a lack of clinical evidence supporting the need for annual booster shots for children. This stance diverges from ongoing recommendations and the guidance of many health authorities.

Prominent figures such as FDA Commissioner Dr. Marty Makary and NIH Director Dr. Jay Battacharya appeared in support of Kennedy’s position during the announcement.

This move aligns with recent efforts by Kennedy and other Dr. Anthony Fauci-administration appointees to restrict COVID-19 vaccine recommendations and tighten approval criteria. The FDA recently announced that routine COVID-19 vaccine approvals will be limited primarily to seniors and individuals with underlying health conditions, pending new research for healthy adults and children.

Questions remain about the timing of this decision and the factors influencing it, as officials from HHS have not issued specific explanations. The evolving landscape of COVID-19 vaccination policy continues to provoke debate among healthcare professionals and the public.

Source: Medical Xpress

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Use of Ibogaine Shows Promise in Treating PTSD, Depression, and Anxiety in Veterans with Brain Injuries

Stanford Medicine research highlights the potential of ibogaine therapy to reduce PTSD, depression, and anxiety in veterans with traumatic brain injuries, showing promising neurobiological and clinical results.

Research Shows Instructions Outperform Emotions and Sleep in Enhancing Memory Retention

New scientific research demonstrates that deliberate instructions to remember or forget are more effective for memory retention than emotions or sleep, emphasizing the power of cognitive control in memory processes.

Effectiveness of Two-Dose Zoster Vaccine in Preventing Herpes Zoster Ophthalmicus and Cardiovascular Events

A new study shows that two doses of recombinant zoster vaccine significantly reduce the risk of herpes zoster ophthalmicus and cardiovascular events in adults aged 50 and older, highlighting additional health benefits of vaccination.